However, constipation becomes more concerning when it occurs with severe swelling, vomiting, intense pain, or inability to pass gas
Liraglutide at 3.0 mg produced mean reductions near 8% in major trials, clinically meaningful but smaller than the newer agents effects
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study
Gentle movement, particularly walking for 10-15 minutes after meals, may help reduce symptoms for some people by promoting movement of gas through the digestive system
Beyond weight loss , GLP-1 weight management medications offer additional health benefits, including: Improved blood sugar control Lowered cardiovascular risk Reduced inflammation and metabolic health improvements Most patients start noticing appetite suppression and weight loss within a few weeks, with more substantial results appearing over months of consistent use